Sol-Gel Technologies Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SLGL research report →
Companywww.sol-gel.com
Sol-Gel Technologies Ltd. , a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream that has completed Phase III clinical trials for the treatment of papulopustular rosacea; SGT-210, which is in Phase I clinical trial for the treatment of palmoplantar keratoderma; and Erlotinib, Tapinarof, and roflumilast to treat psoriasis and other medical conditions.
- CEO
- Moshe Arkin
- IPO
- 2018
- Employees
- 34
- HQ
- Ness Ziona, IL
Price Chart
Valuation
- Market Cap
- $183.46M
- P/E
- -29.69
- P/S
- 9.46
- P/B
- 7.97
- EV/EBITDA
- 15.92
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 100.00%
- Op Margin
- -39.16%
- Net Margin
- -31.60%
- ROE
- -24.29%
- ROIC
- -31.32%
Growth & Income
- Revenue
- $19.39M · 68.04%
- Net Income
- $-6,127,000 · 42.09%
- EPS
- $-2.20 · -478.95%
- Op Income
- $-7,592,000
- FCF YoY
- 101.98%
Performance & Tape
- 52W High
- $97.97
- 52W Low
- $6.80
- 50D MA
- $75.20
- 200D MA
- $51.43
- Beta
- 1.17
- Avg Volume
- 38.51K
Get TickerSpark's AI analysis on SLGL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 13, 26 | Opaleye Management Inc. | buy | 1,937 |
| May 12, 26 | Opaleye Management Inc. | buy | 1,500 |
| Mar 24, 26 | Opaleye Management Inc. | buy | 34,665 |
| Mar 24, 26 | Opaleye Management Inc. | buy | 5,000 |
| Mar 18, 26 | Yosef Itzik | other | 2,031 |
| Mar 18, 26 | Yosef Itzik | other | 566 |
| Mar 18, 26 | Yosef Itzik | other | 499 |
| Mar 18, 26 | Ben-Or Eyal | other | 0 |
| Mar 18, 26 | Ben-Or Eyal | other | 360 |
| Mar 18, 26 | Ben-Or Eyal | other | 180 |
Our SLGL Coverage
We haven't published any research on SLGL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SLGL Report →